🔎 Trials Near Me

Akèy › Poliradikiloneyropati demyelinizan enflamatwa kwonik › New York › New York City

Etid klinik pou Poliradikiloneyropati demyelinizan enflamatwa kwonik nan New York City, NY

7 etid pou Poliradikiloneyropati demyelinizan enflamatwa kwonik ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Ap rekriteFaz 2
  • Site Number - 1605, New York
  • Site Number - 1627, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07032662

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Ap rekriteFaz 3
  • Hospital for Special Surgery - Site Number : 8400041, New York
  • Columbia University Irving Medical Center- Site Number : 8400003, New York
  • Lenox Hill Hospital- Site Number : 8400051, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06290141

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Ap rekriteFaz 1
  • TG Therapeutics Investigational Trial Site, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Ap rekriteFaz 3
  • GC2402 Study Site 110, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07540221

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Ap rekriteFaz 3
  • Clinical Study Site, New York
  • Clinical Study Site, New York
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06858579

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Ap rekriteFaz 1
  • Columbia University Irving Medical Center, New York
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07304154

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Ap rekriteFaz 3
  • NYU Langone Health, New York
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06747351

Etid Poliradikiloneyropati demyelinizan enflamatwa kwonik nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.